Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant
Setsuko Mise‐Omata, Mari Ikeda, Masaru Takeshita, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 11, pp. 2104-2113
Open Access | Times Cited: 19

Showing 19 citing articles:

Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
Bowen Li, Allen Yujie Jiang, Idris Raji, et al.
Nature Biomedical Engineering (2023)
Closed Access | Times Cited: 68
Enhanced detection of antigen-specific T cells by a multiplexed AIM assay
Audrée Lemieux, Gérémy Sannier, Alexandre Nicolas, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 1, pp. 100690-100690
Open Access | Times Cited: 7
Chemokine receptors in COVID-19 infection
Claudia Gutierrez-Chavez, Shalom Aperrigue-Lira, Brando Ortiz-Saavedra, et al.
International review of cell and molecular biology (2024), pp. 53-94
Closed Access | Times Cited: 4
Increase in antibody titer and change over time associated with severe acute respiratory syndrome coronavirus 2 infection after mRNA vaccination: Consideration of the significance of additional vaccination
Hiroshi Kusunoki, Michiko Ohkusa, Rie Iida, et al.
Clinical Case Reports (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 3
Increase in Antibody Titer and Change over Time Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection after mRNA Vaccination: Consideration of the Significance of Additional Vaccination
Hiroshi Kusunoki, Michiko Ohkusa, Rie Iida, et al.
(2024)
Open Access | Times Cited: 2
Longitudinal Analysis of Nursing Home Residents’ T-Cell Responses After SARS-CoV-2 mRNA Vaccinations Shows Influence of Biological Sex and Infection History
Carson L. Smith, Elise M. Didion, Htin Aung, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. 635-644
Open Access | Times Cited: 1
Long-term levels of protection of different types of immunity against the Omicron variant: a rapid literature review
Sabina Rodriguez Velásquez, Loza Biru, Sandrine Marie Hakiza, et al.
Schweizerische medizinische Wochenschrift (2024) Vol. 154, Iss. 5, pp. 3732-3732
Open Access | Times Cited: 1
RBD specific B-cell Memory Responses among Vaccinated Individuals against SARS-CoV-2
Atharv Athavale, A Gaur, Nafees Ahmed, et al.
(2024)
Open Access | Times Cited: 1
Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis
Tjalf Ziemssen, Eugen Schlegel, Marie Groth, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 978-978
Open Access | Times Cited: 4
Adverse Reactions after Booster SARS-CoV-2 Vaccination Have Less Impact on Antibody Response than after Basic Vaccination Scheme
Andrea Kanizsai, László Závori, Tihamér Molnár, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 182-182
Open Access | Times Cited: 2
SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy
Ilaria Vicenti, Monica Basso, Nicole Pirola, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 871-871
Open Access | Times Cited: 2
A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines
Yuting Tan, Shi Zou, Fangzhao Ming, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
The humoral and cellular immune responses following booster vaccination with SARS-CoV-2 mRNA in people living with human immunodeficiency virus
Yuji Matsumoto, Masayuki Murata, Azusa Ohta, et al.
Journal of Infection and Chemotherapy (2023) Vol. 30, Iss. 5, pp. 417-422
Closed Access | Times Cited: 2
Restricted Omicron-specific cross-variant memory B-cell immunity after a 3rd dose/booster of monovalent Wuhan-Hu-1-containing COVID-19 mRNA vaccine
Iana H. Haralambieva, Jonathon M. Monroe, Inna G. Ovsyannikova, et al.
Vaccine (2024) Vol. 42, Iss. 4, pp. 912-917
Closed Access
Anti‐spike protein IgG antibody responses up to 3 months after the third dose of the BNT162b2 mRNA vaccine in medical care workers
Harukazu Hirano
Journal of General and Family Medicine (2024) Vol. 25, Iss. 3, pp. 140-145
Open Access
Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults
Kohei Kometani, Takaaki Yorimitsu, Norihide Jo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Receptor Binding Domain-Specific B Cell Memory Responses Among Individuals Vaccinated Against SARS-CoV-2
Atharv Athavale, A Gaur, Nafees Ahmed, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1396-1396
Open Access
Exponential decline, ceiling effect, downregulation, and T-cell response in immunoglobulin G antibody levels after messenger RNA vaccine boosters: a case report
Harukazu Hirano, Hiroshi Asada
Journal of Medical Case Reports (2024) Vol. 18, Iss. 1
Open Access
Multiparametric analysis of the specific immune response against SARS-CoV-2
Lucie Vránová, Ingrid Poláková, Šárka Vaníková, et al.
Infectious Diseases (2024) Vol. 56, Iss. 10, pp. 851-869
Open Access
Page 1

Scroll to top